ATXS - Astria Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$17.33
DETAILS
HIGH:
$26.00
LOW:
$13.00
MEDIAN:
$13.00
CONSENSUS:
$17.33
UPSIDE:
37.76%
Market Cap:
718.13M
Volume:
3,057,633
Avg Volume:
1,065,178
52 Week Range:
3.555-13.29
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.02
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
78
IPO Date:
2015-06-25
EPS (TTM):
-1.68
P/E Ratio:
-5.33
Revenue (TTM):
N/A
Total Assets:
342.36M
Total Debt:
5.35M
Cash & Equiv:
59.82M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-34.5%
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-0.55 | $-0.41 | -34.1% | $706000 | $10.7M | -93.4% |
| 2025-08-12 | $-0.57 | $-0.61 | +6.6% | — | $10.7M | — |
| 2025-05-13 | $-0.58 | $-0.48 | -20.8% | — | — | — |
| 2025-03-11 | $-0.44 | $-0.45 | +2.2% | — | — | — |
| 2024-11-13 | $-0.42 | $-0.42 | 0.0% | — | — | — |
| 2024-08-12 | $-0.43 | $-0.37 | -16.2% | — | — | — |
| 2024-05-09 | $-0.38 | $-0.35 | -8.6% | — | — | — |
| 2024-03-04 | $-0.86 | $-0.69 | -24.6% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 500,000 | 0 | 0 | 0 | 0 |
| Net Income | (94.26M) | (72.89M) | (51.83M) | (194.91M) | (37.30M) | (26.29M) | (25.87M) | (27.36M) | (36.06M) | (32.63M) | (21.88M) | (18.12M) |
| EPS | -1.68 | -2.42 | -3.55 | -24.58 | -12.20 | -14.06 | -30.71 | -75.73 | -133.31 | -243.45 | -151.53 | -125.45 |
| Total Assets | 342.36M | 254.67M | 230.63M | 127.51M | 47.46M | 41.78M | 39.17M | 17.90M | 40.21M | 64.22M | 15.96M | 31.00M |
| Total Debt | 5.35M | 329,000 | 939,000 | 365,000 | 1.05M | 2.25M | 0 | 2.48M | 5.72M | 8.95M | 4.75M | 0 |
| Cash & Equivalents | 59.82M | 175.53M | 20.52M | 86.51M | 24.93M | 9.90M | 15.29M | 16.37M | 23.60M | 62.78M | 14.67M | 30.47M |
| Operating Cash Flow | (81.21M) | (68.44M) | (43.53M) | (30.15M) | (32.48M) | (26.57M) | (23.46M) | (26.84M) | (32.86M) | (29.79M) | (20.41M) | (16.37M) |
| Free Cash Flow | (81.54M) | (68.47M) | (43.62M) | (30.17M) | (32.52M) | (26.58M) | (23.45M) | (26.89M) | (33.32M) | (30.21M) | (20.64M) | (16.41M) |
| FCF per Share | -1.45 | -2.27 | -2.98 | -3.38 | -10.63 | -14.24 | -27.83 | -74.42 | -123.17 | -225.42 | -142.91 | -113.62 |
| Book Value | 319.26M | 243.12M | 221.22M | 122.31M | 40.67M | 35.72M | 34.94M | 11.79M | 29.09M | 50.49M | (73.05M) | (52.18M) |
| Cash & ST Investments | 328.13M | 246.53M | 226.44M | 125.51M | 44.93M | 36.24M | 37.57M | 16.37M | 38.53M | 62.78M | 14.67M | 30.47M |
| ROC Equity | -0.30 | -0.30 | -0.23 | -1.59 | -0.92 | -0.74 | -0.74 | -2.32 | -1.24 | -0.65 | N/A | N/A |